Ayurvedic management of Vishthabdhajirna(indigestion).

Comparative Study on Mrudu Virechan effect of Trivrut Ghana vati and Aragwadha Ghanavati in management of Vishthabdhajirna

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029572

Enrollment

Registered

2020-12-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Trivrut Ghana vati: It contains Trivrut and will be given by oral route at dose of 500mg twice a day with luke warm water after meal for 15 days Control Intervention1: Aragwadh Ghanavat

Eligibility

Inclusion criteria

Inclusion criteria: Subject of age group 20-50 years Subjects fulfilling the criteria of Rome-III Questionaries

Exclusion criteria

Exclusion criteria: Known case of anorectal disease like anal fissure, Fistula in ano, Cirrhosis of liver, renalfailure, congestive cardiac failure.

Design outcomes

Primary

Measure	Time frame
To check the effects on Bristol Stool Scale and modified ROME-III questionnaire moduleTimepoint: 30 days	—

Secondary

Measure	Time frame
To compare the effects of both groupsTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Vinod Ade

Datta Meghe Institute of Medical Sciences,Wardha

drshwetaparve@gmail.com9403142270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026